Targeting Interleukin-13 with Tralokinumab Attenuates Lung Fibrosis and Epithelial Damage in a Humanized SCID Idiopathic Pulmonary Fibrosis Model

The aberrant fibrotic and repair responses in the lung are major hallmarks of idiopathic pulmonary fibrosis (IPF). Numerous antifibrotic strategies have been used in the clinic with limited success, raising the possibility that an effective therapeutic strategy in this disease must inhibit fibrosis...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Murray, Lynne A., Zhang, Huilan, Oak, Sameer R., Coelho, Ana Lucia, Herath, Athula, Flaherty, Kevin R., Lee, Joyce, Bell, Matt, Knight, Darryl A., Martinez, Fernando J., Sleeman, Matthew A., Herzog, Erica L., Hogaboam, Cory M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Thoracic Society 2014
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4068948/
https://ncbi.nlm.nih.gov/pubmed/24325475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1165/rcmb.2013-0342OC
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller